Literature DB >> 32138523

Assessing HIV provider knowledge, screening practices, and training needs for HIV-associated neurocognitive disorders. A short report.

Hetta Gouse1, Catherine J Masson1, Michelle Henry2, Thomas D Marcotte3, Leslie London4, Greg Kew4, Sean Rourke5, Reuben N Robbins6.   

Abstract

Management of HIV-associated neurocognitive disorders (HAND) is becoming increasingly important with HIV-positive people living normal life spans. We aimed to establish the level of HAND awareness among doctor and nurse occupational health practitioners, screening used to detect impairment, factors limiting screening for HAND, and training needs. One-hundred-and-five members of the nursing and physician professional societies for occupational health practitioners in South Africa and Occupational Health Departments at five South African universities responded to an email invitation to complete an online survey addressing demographics, HAND knowledge, screeners being used to screen for HAND and related training needs. While 80% had heard of HAND, few (13.3%) were aware of the Frascati criteria. Only 2% had received training addressing HAND; 11.4% screened for HAND; 45.7% did not know what screening tool to us; 80% preferred spending <15 min on screening. The largest obstacle to screening was lack of expertise (77.1%) but 77.3% thought it important to screen for HAND. 94.3% wanted screening training. Health providers are poorly informed about HAND and lack expertise and tools to screen for HAND in their treatment programs. While few had relevant training, they recognize the importance of screening for HAND in the workplace and desire training.

Entities:  

Keywords:  HIV; HIV-associated neurocognitive disorders (HAND); mental health; neurocognitive impairment; screening; workplace management

Mesh:

Year:  2020        PMID: 32138523      PMCID: PMC7483165          DOI: 10.1080/09540121.2020.1736256

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  6 in total

1.  Impact of HIV on Cognitive Performance in Professional Drivers.

Authors:  Hetta Gouse; Catherine J Masson; Michelle Henry; Anna Dreyer; Reuben N Robbins; Greg Kew; John A Joska; Leslie London; Thomas D Marcotte; Kevin G F Thomas
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

2.  Worldwide Occurrence of HIV-Associated Neurocognitive Disorders and Its Associated Factors: A Systematic Review and Meta-Analysis.

Authors:  Yosef Zenebe; Mogesie Necho; Wondwosen Yimam; Baye Akele
Journal:  Front Psychiatry       Date:  2022-05-31       Impact factor: 5.435

3.  Construct Validity Supports Use of a Novel, Tablet-Based Neurocognitive Assessment for Adolescents and Young Adults Affected by Perinatal HIV from Vulnerable Communities in the United States.

Authors:  R N Robbins; L Kluisza; J Liu; A F Santoro; J Raymond; N Ngyuen; S Espinel; E Siegel; C Dolezal; A Wiznia; E J Abrams; C A Mellins
Journal:  AIDS Behav       Date:  2020-11-12

4.  Integrating HIV-Associated Neurocognitive Impairment Screening within Primary Healthcare Facilities: A Pilot Training Intervention.

Authors:  Adele Munsami; Goodman Sibeko; Hetta Gouse; Sam Nightingale; John A Joska
Journal:  Nurs Res Pract       Date:  2022-08-13

5.  Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective.

Authors:  Adele Munsami; Sam Nightingale; Katherine Sorsdahl; John A Joska
Journal:  Qual Health Res       Date:  2022-06-30

6.  The Impact of HIV-Associated Neurocognitive Impairment on Driving Performance in Commercial Truck Drivers.

Authors:  H Gouse; C J Masson; M Henry; K G F Thomas; R N Robbins; G Kew; L London; J A Joska; T D Marcotte
Journal:  AIDS Behav       Date:  2021-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.